Four “Rich Guy Favorite” Dividends Up to 10.7%

Our Archive

Search completed

Four “Rich Guy Favorite” Dividends Up to 10.7%

“Hey Brett, how’s business?”

“Awful,” I admitted. “But we’re a startup. If we can improve from awful to simply bad, it will be a big milestone for us.”

That was one economic meltdown ago, back in 2008. I had just left my “day job” to start my first company. On cue, the Great Recession descended upon us.

But the gloomy economic backdrop didn’t matter. Actually, it was a blessing. A recession is actually the best time to start companies and grow them.

As a startup with no money, we were able to cobble our limited resources together to get the company off the ground.… Read more

Read More

This 6.3% Blue Chip Is Dialed in for Steady Gains Ahead

Wall Street has been giving investors whiplash lately, as the big rebound from July evaporated in August. And as we look to close out the year, more volatility is sure to follow.

Most financial news channels blame the choppy environment on rising interest rates, rampant inflation or other macroeconomic boogeymen. But that’s just because the media needs to keep you clicking on headlines if they want to get paid! The real reason for recent volatility is much simpler.

It’s not really troublesome data points driving the market, but rather troublesome bouts of “first order” thinking.

Spend time around toddlers or pets and you’ll see the perils of first order thinking on display.… Read more

Read More

The “Biden Biotech Boom” Will Send This Bargain 6.8% Dividend Soaring

Some major—and almost totally ignored—news from Washington, D.C., is about to upend the biotech world, turning America into “the world’s pharmacy” in short order—and giving us a chance to buy a solid 6.8% dividend for just 91 cents on the dollar.

That might sound hard to believe for woebegone biotechs, which have fallen further than the S&P 500 this year, going by the performance of the benchmark iShares Biotechnology ETF (IBB). That’s despite the sector’s importance during the pandemic—and despite the fact that some 10,000 Americans turn 65 every day, sharply increasing demand for pharmaceuticals as the senior cohort grows.

Biotech Catches a Cold

The problem is that despite these tailwinds, biotech is weighed down by the same problems that are dragging on the rest of the economy: lower R&D funding as interest rates rise, and supply-chain issues that are hurting productivity.… Read more

Read More

This Dividend Catalyst Creates Safe 15% Yearly Returns

Why chase the market when we can let 15% per year—every year—come to us?

This is the perfect time to buy what I call “hidden yield” investments. These are stocks that dish out dividends today. But, more notably, they have an important catalyst coming in the year ahead that will help boost their stock prices.

This trigger is so powerful that it sends these stocks sailing by 15% or more per year, every year. Which is truly great when other equities and even bonds are getting buried around us.

We’ll talk about these stocks and their “dividend spark” in a moment.… Read more

Read More

These 2 Smart “Deglobalization” Trades Are Gushing Dividend Cash

“Deglobalization” is the dividend trade of the 2020s. And we’re going to tap it for safe dividend growers with real assets and real cash flow.

I’ll drop two tickers in a second.

Signs that our interconnected world is coming unglued are everywhere. Supply chains are still a mess. Europe is getting set to ban (or slap a price cap on) Russian oil. Speaking of Putin, his immoral invasion of Ukraine is, er, not going well. He’s even going cap in hand to North Korea for spare parts for his ramshackle military!

Meanwhile, Chinese President Xi gazes across the Taiwan Strait, while shuttering his own economy (and vital trading ports) in pursuit of his insane zero-COVID policy.… Read more

Read More

Prediction: This 9.9%-Yielding Fund Will Crush Stocks in ’23

Most folks don’t know it, but real estate has clobbered stocks in the long run, and it’s poised to pull off a win again in 2023.

And we dividend investors are nicely lined up to cash in, thanks to a fund throwing off a blockbuster 9.9% yield that’s the perfect play here. I’ll drop the name and ticker in a sec.

First, you read that right: real estate does outperform stocks over the long haul—and by no small amount, either! It’s clear as can be in this comparison between the SPDR Dow Jones REIT ETF (RWR), the index fund for publicly traded real estate investment trusts (REITs), and the S&P 500 over the last 20 years.… Read more

Read More

Are Utilities Still the No. 1 Safety Play?

Utility stocks—the “OGs of dividend payers”—have sailed through 2022. We’ll highlight seven of them, yielding 4% or more, in a moment.

By the way, this sector-at-large has returned 4%, including dividends, year-to-date (YTD). While that may not make us rich, it is the best record on the scoreboard this side of energy:

Why utilities? As always, these stocks pay and they don’t drop as much in price as the broader market. A useful quality in a dumpster-fire market.

Utilities are expensive, however, They currently trade at nearly 21 times forward earnings—near their highest forward P/E in decades and well above the S&P 500 forward P/E of 17.7.… Read more

Read More

Snag 7%+ Yield in This Crash-Proof Energy Stock

If you did any driving over the holiday weekend, you may have noticed that prices at the pump are much more manageable than they were just a few months ago. In fact, they recently hit their lowest level since mid-February.

That’s great for motorists, but has admittedly created plenty of pain for investors who thought the windfall profits in the oil patch were sustainable. Consider that the popular Energy Select Sector SPDR Fund (XLE) made up of blue chip energy stocks is down almost 15% from its June high, while the S&P 500 on average has managed to post a small gain in the same period.… Read more

Read More

Buy This 7.5% Dividend to Profit From a September Market Storm

By now you’ve likely heard that September is the worst month for stocks. It’s all over the media! But September is also a great time to buy a unique type of dividend fund that cashes in when volatility rears up (these funds will pay you blockbuster yields north of 7%, too!).

I’m talking about a special type of closed-end fund (CEF) called a covered-call fund, which makes more money every time the market panics. They then turn that cash over to us in the form of a dividend that crushes anything you’d get on a blue-chip stock or Treasury.

Don’t let the jargon-y name throw you.… Read more

Read More

How Peter Thornhill Collects $400K Per Year in Dividends

Peter is an investing legend. Dude collects $400,000 per year in dividend income.

He retired at age 53, by the way. From the finance industry, naturally. Peter wrote a book and cruised around as a public speaker.

The speaking fees and book royalties were gravy, no doubt. With $33,000 in dividend income coming in each month, I’m sure Peter does not sweat his bills.

Now what can we contrarian income investors learn from master dividend investor “Payout” Peter Thornhill?

Not much.

The guy has an $11 million portfolio. Of course his dividend cash flow is going to rock. It may only be 4%, but that’s more than enough when this is the pile he’s deploying:

A simpler investor can do just as well with a similar war chest.… Read more

Read More

Categories